Megaport Appoints IT Industry Veteran Jim Brinksma to the Executive Team as Chief Technology Officer
Jim Brinksma joins Megaport as Chief Technology Officer after senior IT leadership roles at Ciena BluePlanet, Goldman Sachs, and InnovoEdge...
Wire Stories
Category Added in a WPeMatico Campaign
Indian Clinical Trials Market Size, Share & Trends Analysis, 2022-2030 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Indian Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III,...
Global Portable CMM Market Report 2022-2025: Increasing Preference for New Technology Expands the Need for Inline Measurement and Inspection – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Portable CMM Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research analyzes the global trends...
China Prepaid Card and Digital Wallet Markets Databook 2022: Market Size and Forecasts, Consumer Attitude & Behaviour, Retail Spending, 2017-2021 & 2022-2026 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Prepaid Card and Digital Wallet Business and Investment Opportunities Databook - Market Size and Forecast, Consumer Attitude...
Malaysia Prepaid Card and Digital Wallet Markets and Investment Opportunities Report 2022: Market is Expected to Record a CAGR of 14.4%, Increasing from $6.06 Billion in 2022 to $10.40 Billion by 2026 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Malaysia Prepaid Card and Digital Wallet Business and Investment Opportunities Databook - Market Size and Forecast, Consumer Attitude...
Ideon Technologies Announces Dr. Alan Bye as Advisor
VANCOUVER, British Columbia--(BUSINESS WIRE)--#cleantech--Ideon Technologies is pleased to announce that Dr. Alan Bye, PhD has been appointed as an advisor...
Asia Pacific Embedded Payment Markets and Investment Opportunities Report 2022: Market is Expected to Grow by 41.8% to Reach $54.29 Billion in 2022 – Forecast to 2029 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Embedded Payment Business and Investment Opportunities - Q1 2022 Update" report has been added to ResearchAndMarkets.com's...
Pherecydes Pharma Extends Its Intellectual Property in China With a First Patent Granted for Its anti-Pseudomonas aeruginosa Phages in This Territory
NANTES, France--(BUSINESS WIRE)--Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 – ALPHE), a biotechnology company specializing in precision phage therapy to treat...
Postcard Game Studio Secures $3.5 Million Seed Investment from Smilegate
New AAA Game Studio comprised of Naughty Dog, Bungie, Guerrilla Games, and 343 Industries Veterans IRVINE, Calif.--(BUSINESS WIRE)--In an effort...
Cega Raises $4.3M from Dragonfly, Pantera to Build the First Exotic Structured Products in Cryptocurrency
SINGAPORE--(BUSINESS WIRE)--#cega--Cega Finance (“Cega”), the first decentralized finance (“DeFi”) exotic structured products protocol, announced today that it raised a $4.3M...
Clearlake Capital-Backed Dude Solutions Rebrands to Brightly Software
New brand reflects Company’s vision to leverage software and data to power smarter assets and sustainable communities with intelligent asset...
Atlas Announces Market Expansion and Sustainability Plans, as the Company Doubles Down on Web 3.0
Plans include achieving 3X geographical expansion and 100% green energy by 2024 SINGAPORE--(BUSINESS WIRE)--#Blockchain--Atlas Technology Management (Atlas), the Singapore headquartered...
8×8 XCaaS™ Achieves Another Industry First; Now Delivers Integrated Cloud Contact Center and Phone Solutions for Multinational Companies in Indonesia
Now Available in Indonesia and Thailand; Offers Highest Quality of Service and Reliability for Employees and Contact Center Agents in...
Appen Invests in Synthetic Data Business Mindtech
As the leader in data for the AI lifecycle, Appen is investing in emerging training data sources. SYDNEY--(BUSINESS WIRE)--Appen Limited,...
Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles
SYDNEY--(BUSINESS WIRE)--#Covid19--Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a...
